Εμφανίζονται 1 - 20 Αποτελέσματα από 49 για την αναζήτηση '"прогностические критерии"', χρόνος αναζήτησης: 0,71δλ Περιορισμός αποτελεσμάτων
  1. 1
    Academic Journal

    Συγγραφείς: T.V. Sorokman, N.O. Popeliuk

    Πηγή: Mìžnarodnij Endokrinologìčnij Žurnal, Vol 16, Iss 2, Pp 138-144 (2020)
    Міжнародний ендокринологічний журнал-Mìžnarodnij endokrinologìčnij žurnal; Том 16, № 2 (2020); 138-144
    Международный эндокринологический журнал-Mìžnarodnij endokrinologìčnij žurnal; Том 16, № 2 (2020); 138-144
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY; Том 16, № 2 (2020); 138-144

    Περιγραφή αρχείου: application/pdf

  2. 2
    Academic Journal

    Συγγραφείς: Perepada, Ganna

    Πηγή: ScienceRise: Medical Science; № 1 (28) (2019); 24-31
    ScienceRise. Medical Science; № 1 (28) (2019); 24-31

    Περιγραφή αρχείου: application/pdf

  3. 3
  4. 4
  5. 5
    Academic Journal

    Περιγραφή αρχείου: application/pdf

    Relation: Черкашина Л. В. Дослідження факторів ризику, розробка критеріїв та обґрунтування алгоритму прогнозування псоріазу на етапі первинної медичної допомоги / Л. В. Черкашина // Актуальні проблеми сучасної медицини: Вісник Української медичної стоматологічної академії. – 2018. – Т. 18, вип. 3 (63). – С. 147–152.; https://repository.pdmu.edu.ua/handle/123456789/12351

  6. 6
    Academic Journal
  7. 7
  8. 8
    Academic Journal

    Πηγή: The Russian Archives of Internal Medicine; Том 6, № 4 (2016); 14-20 ; Архивъ внутренней медицины; Том 6, № 4 (2016); 14-20 ; 2411-6564 ; 2226-6704 ; 10.20514/2226-6704-2016-6-4

    Περιγραφή αρχείου: application/pdf

    Relation: https://www.medarhive.ru/jour/article/view/548/518; Авдеев С.А. Хроническая обструктивная болезнь легких: обострения. Пульмонология. 2013; 3: 5-18. Avdeev S.N. Acute exacerbation of chronic obstructive pulmonary disease. Pulmonology. 2013; (3): 5-18 (in Russian).; Дворецкий Л.И. Остеопороз у больных ХОБЛ: коморбидность или системное проявление? Consilium Medicum. 2007; 9(12): 42-48. Dvoretsky L.I., Chistyakova E.M. Оsteoporosis in patients with chronic obstructive pulmonary disease: is it comorbidity or a systemic manifestation? Consilium Medicum. 2007; 9(12): 42-48 (in Russian).; Agustí A., Edwards L.D., Rennard S.I. et al. 2012. Persistent systemic inflammation is associated with poor clinical outcomes in COPD: A novel phenotype. PLoS ONE 7(5): e37483. http://dx.doi. org/10.1371/journal.pone.0037483.; Agustí A., Faner R. Systemic Inflammation and Comorbidities in Chronic Obstructive Pulmonary Disease. Proceedings of the American Thoracic Society. 2012; 9(2): 43-46.; Agusti A, Vestbo J. Current controversies and future perspectives in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2011; 184: 507–513.; Bakakos P., Kostikas K., Loukides S. COPD and comorbidities. 2010, 23(1): 24-27.; Barnes P.J., Celli B.R. Systemic manifestations and comorbidities of COPD Eur. Respir. J. 2009; 33: 1165–1185.; Calverley P.M.A., Anderson J.A., Celli B. et al. Cardiovascular events in patients with COPD: TORCH Study results. Thorax. 2010; 65: 719-725.; Caram L.M., Ferrari R., Naves C.R. Association between left ventricular diastolic dysfunction and severity of chronic obstructive pulmonary disease. Clinics (Sao Paulo). 2013; 6: 772-776.; Celli B.R., Cote C.G., Lareau S.C. et al. Predictors of Survival in COPD: More than Just the FEV1. Respir. Med. 2008; 102(Supplement 1): 27–35.; Cote C.G., Pinto-Plata V.M., Marin J.M. et al. The modified BODE index: validation with mortality in COPD. Eur. Respir. J. 2008; 32: 1269–1274.; Drummond M., Hansel N., Connett J. et al . Spirometric predictors of lung function decline and mortality in early chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2012; 185: 1301–1306.; Footitt J., Mallia P., Durham A.L. et al. Oxidative and Nitrosative Stress and Histone Deacetylase-2 Activity in Exacerbations of COPD. Chest. 2016; 149: 62-73.; Gan W.Q., Man S.F., Senthilselvan A., Sin D.D. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a metaanalysis. Thorax. 2004; 59: 574– 580.; Garcia-Aymerich J., Lange P., Benet M., Schnohr P. et al. Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax. 2006; 61(9): 772-778.; McGarvey L.P., Magder S., Burkhart D. et al. Cause-specific mortality adjudication in the UPLIFT® COPD trial: Findings and recommendations. Respiratory Medicine. 2012; 106(4): 515–521.; Gaur S.N., Goel N. Systemic Manifestations of COPD. Medicine Update. 2012; 22: 386-389.; Global Initiative for Chronic Obstructive Lung Disease (GOLD). http://www.goldcopd.org/uploads/users/files/GOLD_Report_2011_ Feb21.pdf. Revised 2011; L. Graat-Verboom, Wouters E.F.M., Smeenk F.W.J.M., van den Borne B.E.E.M., Lunde R., Spruit M.A. Current status of research on osteoporosis in COPD: a systematic review. Eur. Respir. J. 2009; 34: 209–218.; Graat-Verbooma L., Smeenka F.W.J.M., van den Bornea B.E.E.M. et al. Progression of osteoporosis in patients with COPD: A 3-year follow up study. Respiratory Medicine. 2012; 106(60: 861–870.; Halpin D.M., Decramer M., Celli B., Kesten S., Liu D. Exacerbation frequency and course of COPD. Int. J. Chron. Obstruct. Pulmon. Dis. 2012; 7: 653–661.; Huang Y.S., Feng Y.C., Zhang J. Impact of chronic obstructive pulmonary diseases on left ventricular diastolic function in hospitalized elderly patients. Clin. Interv. Aging. 2014; 10: 81-87.; Hurst J., Vestbo J., Anzueto A. et al . Susceptibility to exacerbation in chronic obstructive pulmonary disease. N. Engl. J. Med. 2010; 363: 1128–1138.; Jenkins C.R., Celli B., Anderson J.A., Ferguson G.T., Jones P.W. Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH study. Eur. Respir. J. 2012, 39: 38–45.; Johns D.P., Walters J.A., Walters E.H. Diagnosis and early detection of COPD using spirometry. J. Thorac. Dis. 2014; 6: 1557–1569.; Jones P.W., Chen W.H., Wilcox T.K., Sethi S., Leidy N.K. Characterizing and quantifying the symptomatic features of COPD exacerbations. Chest. 2011; 139: 1388–1394.; Lankeit M., Held M. Incidence of venous thromboembolism in COPD: linking inflammation and thrombosis? Eur. Respir. J. 2016; 47: 369–373.; Mannino D.M., Make B.J. Is it time to move beyond the “O” in early COPD? Eur. Respir. J. 2015; 46: 1535–1537.; Mannino D.M., Thorn D., Swensen A., Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur. Respir. J. 2008; 32: 962–969.; Martinez F.J., Raczek A.E., Seifer F.D. qt al. COPD-PS Clinician Working Group. Development and initial validation of a self-scored COPD Population Screener Questionnaire (COPD-PS). COPD. 2008; 5(2): 85-95.; Miller A., Raskin J.M. The natural history of COPD: confirming and going beyond Fletcher and Peto. Eur. Respir. J. 2014; 44: 280–283.; Miravitlles M., Calle M., Soler-Cataluña J. Clinical phenotypes of COPD: identification, definition and implications for guidelines. Arch. Bronconeumol. 2012; 48: 86–98.; Sinden N.J., Stockley R.A. Chronic obstructive pulmonary disease: an update of treatment related to frequently associated comorbidities. Ther. Adv. Chronic. Dis. 2010; 1(2): 43–57.; Nishimura M., Makita H., Nagai K. et al . Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care. Med. 2012; 185: 44–52.; Nussbaumer-Ochsner Y., Rabe K.F. Systemic manifestations of COPD. Chest. 2011; 139(1): 165-173.; Papaioannou A.I., Loukides S., Gourgoulianis K.I., Kostikas K. Global assessment of the COPD patient: Time to look beyond FEV1? Respir. Med. 2009; 103: 650-660.; Quanjer P.H., Tammeling G.J., Cotes J.E. et al. Lung volumes and forced ventilatory flows. Report working party. Standardization of lung function tests. European Community for steel and coal. Official statement of the European Respiratory Society. Eur. Respir. J. 1993; 6: 5–40.; Quint J.K., Donaldson G.C., Hurst J.R. et al. Predictive accuracy of patient-reported exacerbation frequency in COPD. Eur. Respir. J. 2011; 37: 501–507.; Rennard S.I., Drummond M.B. Early chronic obstructive pulmonary disease: definition, assessment, and prevention. Lancet. 2015; 385: 1778–1788.; Sinden N.J., Stockley R.A. Systemic inflammation and comorbidity in COPD: a result of ‘overspill’ of inflammatory mediators from the lungs? Review of the evidence. Thorax. 2010; 65: 930-936.; Valvi D., Mannino D.M., Muellerova H., Tal-Singer R. Fibrinogen, chronic obstructive pulmonary disease (COPD) and outcomes in two United States cohorts. International Journal of Chronic Obstructive Pulmonary Disease. 2012, 7: 173–182.; Vestbo J., Anderson W., Coxson H.O. et al. Evaluation of COPD Longitudinally to Identify Predictive Surrogate End point (ECLIPSE). Eur. Respir. J. 2008; 31: 869–873.; Vestbo J. The TORCH (TOwards a Revolution in COPD Health) survival study protocol. Eur. Respir. J. 2004; 24: 206–210.; Vestbo J., Hurd S., Agusti A. et al . Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am. J. Respir. Crit. Care Med. 2013; 187: 347–365.; Vrieze A., de Greef M.H., Wijkstra P.J., Wempe J.B. Low bone mineral density in COPD patients related to worse lung function, low weight and decreased fat-free mass. Osteoporos. Int. 2007; 18: 1197–1202.; Wedzicha J.A., Brill S.E., Allinson J.P. Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease. BMC Medicine. 2013, 11: 181.; https://www.medarhive.ru/jour/article/view/548

  9. 9
  10. 10
    Academic Journal

    Πηγή: Malignant tumours; № 4s2 (2015); 49-52 ; Злокачественные опухоли; № 4s2 (2015); 49-52 ; 2587-6813 ; 2224-5057

    Περιγραφή αρχείου: application/pdf

    Relation: https://www.malignanttumors.org/jour/article/view/168/178; Hubert Low TH, Gao R, Elliot M, Clark JR. Tumor classification for early oral cancer: re-evaluate the current TNM classification. Head Neck. 2015 Feb; 37(2):233–8. doi:10.1002/hed.23581. Epub 2014 Mar.; J. Shah, S.G Patel. Head and Neck surgery and oncology. Mosby, Edinburg, 2007, p.731.; Pinto FR, de Matos LL, Palermo FC, Kulsar MA, Cavalheiro BG, de Mello ES, Alves VA, Cernea CR, Brandao LG. Tumor thickness as an independent risk factor of early recurrence in oral cavity squamous cell carcinoma. Eur Arch Otorhinolaryngol. 2014 Jun; 271(6):1747–54. Doi:10.1007/s00405–013–2704–9. Epub 2013 Sep 27.; Ariji Y, Goto M, Fukano H, Sugita Y, Izumi M, Ariji E. Role of intraoral Doppler sonograhpy in predicting delayed cervical lymph node metastasis in patients with early-stage tongue cancer: a pilot study. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015 Fed;119(2):246–53. doi:10.1016/j.oooo.2014,10.21. Epub 2014 Nov 11.; Joshi PS, Pol J, Sudesh AS. Ultasonography – A diagnostic modality foe oral and maxillofacial diseases. Conmet Clin Dent. 2014 Jul; 5(3):345–51. doi:10.4103/0976–237X. 137942.; Trojanowska A., Grzycka-Kowalczyk L., Trojanowski P. et al. Computed tomography perfusion examination is helpful in evaluating the extent of oropharyngeal and oral cavity cancer. Pol J Radiol 2011;76(1):14–9.; Dogan E., Sarioglu S., Ada E. et al. Comparison of clinical and pathological staging in oral cavity cancers. Kulak Burun Bogaz Ihtis Derg 2012;22(6):305–10.; Rumboldt Z., Al-Okaili R., Deveikis J. P. Perfusion CT for head and neck tumors: pilot study. Am J Neuroradiol 2005;26(5):1178–85.; С. О. Степанов, Л. А. Митина, В. В. Ратушная, Д. В. Долгачева, В. А. Соловьев Ультрасонографическая диагностика рака языка, Head and Neck/Голова и шея. Российское издание № 3 / 2013: 5–7.; Lwin C. T., Hanlon R., Lowe D. et al. Accuracy of MRI in prediction of tumour thickness and nodal stage in oral squamous cell carcinoma. Oral Oncol 2012;48(2):149–54.; Keberle M., Jenett M., Hahn D. Clinical trial on the accuracy of a freehand and sensor-independent three-dimensional power Doppler ultrasound system measuring diameters, volumes and vascularity of malignant primaries of the neck. Ultraschall Med 2001; 22(2):91–95.; Kumar N, Patel MD. Pattern of lymphatic metastasis in relation to the depth of tumor in oral tongue cancers: a clinic pathological correlation. Indian J Otolaryngol Head Neck Surg.2013 Jul; 65(Suppl1): 59–63.doi:10.1007/ы12070–012–0504-y. Epub 20.; https://www.malignanttumors.org/jour/article/view/168; undefined

  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20